Source comparison
Does PT-141 Help Erectile Function Research: Efficacy Comparison
| Treatment | Mechanism | Onset | Duration | Response Rate (Moderate ED) | Cardiovascular Risk | Professional Assessment ||—|—|—|—|—|—|| PT-141 1.75mg | MC3R/MC4R agonism (CNS) | 30–45 min | 6–12 hours | 48–58% | Minimal. No nitrate interaction | Mechanistical
This comparison does not assign a generated winner or score.
- | Treatment | Mechanism | Onset | Duration | Response Rate (Moderate ED) | Cardiovascular Risk | Professional Assessment ||—|—|—|—|—|—|| PT-141 1.75mg | MC3R/MC4R agonism (CNS) | 30–45 min | 6–12 hours | 48–58% | Minimal. No nitrate interaction | Mechanistically distinct from PDE5 inhibitors. Potential rescue option for vascular-insufficient ED, but nausea limits tolerability || Sildenafil 100mg | PDE5 inhibition (peripheral) | 30–60 min | 4–6 hours | 65–75% | Moderate. Contraindicated with nitrates | First-line standard with established safety profile. Superior response rates in vascular-mediated ED || Tadalafil 20mg | PDE5 inhibition (peripheral) | 30–60 min | 24–36 hours | 70–80% | Moderate. Contraindicated with nitrates | Longer duration supports spontaneity. Preferred for daily low-dose regimens || Apomorphine 3mg | Dopamine D2 agonism (CNS) | 15–20 min | 2–4 hours | 45–55% | Low. Hypotension risk | Faster onset but shorter duration. Largely displaced by PDE5 inhibitors due to tol